Hydroxyprogesterone Caproate and Progesterone Use During Pregnancy

    Basic Details
    Date Posted
    Monday, October 28, 2019
    Status
    Complete
    Medical Product
    hydroxyprogesterone caproate
    progesterone
    Health Outcome(s)
    exposure in pregnancy
    Description

    Our objective was to estimate use of hydroxyprogesterone caproate and progesterone during the second or third trimesters among pregnancies that ended with a live-birth delivery in the Sentinel Distributed Database (SDD). We identified live-birth deliveries occurring between January 1, 2008 to April 30, 2019. We distributed this request on August 5, 2019 to 15 Data Partners contributing to the SDD. 

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2008 - April 30, 2019
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    Females 10 to 54 years of age
    Data Sources
    Sentinel Distributed Database (SDD)